Kopp LeRoy C
CIK
1399913
Location
BLOOMINGTON, MN
Portfolio Value
Micro
$74,856,849
Diversification
Moderately concentrated
Filing Date
Mar 31, 2024
Global Rank
#5,444
/ 7,296
Top Industry
Biotechnology
36.6%
3Y Alpha vs SPY
-38.8%
Period ended 2 years ago
Filed Jun 3, 2024 · 2y
Clone Performance
May 2024–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-35.4%
SPY
+46.2%
Annualised alpha
-38.8%
Max drawdown
−52.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
7 positions · as of Mar 31, 2024Top Position
31.8%
of portfolio value
Top 5
90.7%
of portfolio value
Top 10
100.0%
of portfolio value
HHI
2,009
Moderately concentrated
Sector Breakdown
As of Mar 31, 2024| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 67.2% | $50,285,557 |
| Technology | 32.8% | $24,571,292 |
7 positions ·
$74,856,849 total
· as of Mar 31, 2024
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| VCEL |
Vericel Corp
Healthcare
|
First | 457,615 | $23,805,132 | 31.80% | |
| FIVN |
Five9, Inc.
Technology
|
First | 237,492 | $14,750,628 | 19.71% | |
| NEO |
Neogenomics Inc
Healthcare
|
First | 894,509 | $14,061,681 | 18.78% | |
| INSP |
Inspire Medical Systems, Inc.
Healthcare
|
First | 41,054 | $8,817,988 | 11.78% | |
| WK |
Workiva Inc
Technology
|
First | 76,427 | $6,481,009 | 8.66% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
First | 205,640 | $3,600,756 | 4.81% | |
| MITK |
Mitek Systems Inc
Technology
|
First | 236,855 | $3,339,655 | 4.46% |